Latest News & Articles
Browse all our latest news articles and stories

FAQ on Incora's AS13100 Compliance and AESQ Membership

FAQ: Cynomi's ELEVATE Partner Program for MSP and MSSP Growth

FAQ on AI-Based Speech Tool for Parkinson’s Disease Detection
Computer scientists have developed an AI-based speech screening tool that can help detect early signs of Parkinson’s disease, offering a new avenue …

FAQ: Adaptive Insurance and Whisker Labs Partnership for Real-Time Grid Intelligence in Power Outage Insurance

FAQ: Discovering the Best Orthodontist in Miami for Your Perfect Smile

Navigating the Shift from SEO to GEO in Financial Services Marketing

FAQ on PowerBank Corporation's Partnership with Intellistake on Bitcoin Treasury and Asset Tokenization

FAQ: Understanding Ciroos' AI SRE Teammate and Its Impact on Modern Operations Teams
Ciroos introduces an AI SRE Teammate designed to modernize enterprise operations by automating and augmenting tasks, enabling teams to handle rising …

FAQ: PayPal's New Cryptocurrency Feature and Its Impact

FAQ: Google and Energy Dome's Partnership for Advanced Renewable Energy Storage
Google has partnered with Energy Dome to deploy advanced renewable energy storage solutions globally, aiming to address the intermittency issue of …

FAQ: Ruble-Backed Stablecoin A7A5 and Its $40 Billion Transfer Milestone

FAQ: Gelt's Acquisition of a 678-Unit Self-Storage Property in Napa, California

D-Wave Quantum Inc.'s Advanced Cryogenic Packaging Initiative FAQ

FAQ on Aston Bay Holdings Ltd.'s Summer Field Program at Epworth Project
Aston Bay Holdings Ltd. has initiated a summer field program at its Epworth copper-silver-zinc-cobalt project in Nunavut, focusing on exploring deep …

FAQ on Oragenics Inc.'s Phase IIa Trial of ONP-002 for Concussion Treatment

FAQ: SEGG Media Corporation's Acquisition of GXR Technology Assets and User Base

FAQ on Quantum BioPharma Ltd. and Unbuzzd Wellness's $5 Million Regulation D Offering

FAQ on Soligenix Inc.'s Phase 2a SGX945 Study for Behçet’s Disease
Soligenix Inc. has successfully demonstrated biological efficacy in its Phase 2a study of SGX945 for Behçet’s Disease, showing significant improvement …
